Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in Surgery Retrieve available abstracts of 87 articles: HTML format

Single Articles

October 2025
1. OSORIO-SILLA I, Gonzalez DM, Quiceno Arias HD, Peinado PP, et al
   Differences in histopathologic features and diagnostic performance of (99m)Tc-methoxy-isobutyl-isonitrol single photon emission tomography-CT and (18)F-fluorocholine positron emission tomography-CT in primary hyperparathyroidism.
   Surgery. 2025;186:109595.
   PubMed     Abstract available
   
   
   
2. MICALO L, Cho NY, Liu Z, Mallick S, et al
   Persistent racial disparities in the use of high-volume esophagectomy centers in the United States.
   Surgery. 2025;186:109554.
   PubMed     Abstract available
   
   
   September 2025
3. MYLONAKIS A, Dimitrakoudi M, Vasilatou D, Tsapralis D, et al
   Primary esophageal lymphoma: An individual participant data meta-analysis.
   Surgery. 2025;185:109534.
   PubMed     Abstract available
   
   
   August 2025
4. POLLMANN L, Weberskirch S, Petry M, Kubasch S, et al
   Indocyanine green quantification in full robotic esophagectomy using an unsupervised learning approach.
   Surgery. 2025;184:109405.
   PubMed     Abstract available
   
   
   July 2025
5. VAGHAIWALLA TM, Henriksen EM, Chang J, Saghira C, et al
   Reassessing false-negative rate and size cutoff for papillary thyroid cancer with fine-needle aspiration in thyroid nodules.
   Surgery. 2025;186:109577.
   PubMed     Abstract available
   
   
   
6. LINTIS A, Voron T, Passot G, Degisors S, et al
   Is preoperative smoking status a predictor of postoperative outcomes after esophagectomy for squamous cell carcinoma in a high-volume centre?
   Surgery. 2025;183:109379.
   PubMed     Abstract available
   
   
   May 2025
7. SHAO K, Du Y, Xu L, Jiang Y, et al
   Outcomes of neoadjuvant immunochemotherapy and neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
   Surgery. 2025;183:109383.
   PubMed     Abstract available
   
   
   
8. FORTMANN L, Hoelzen JP, Pascher A, Juratli MA, et al
   Amendment and subsumption of "Insights and comprehensive evaluation on 'Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer'".
   Surgery. 2025 May 2:109369. doi: 10.1016/j.surg.2025.109369.
   PubMed    
   
   
   
9. ZHAO Z, Huang W, Fu Y, Ji W, et al
   Comparative analysis of cis-cutting and retro-cutting techniques in gastric tube fabrication for preventing postoperative anastomotic leakage after esophagectomy.
   Surgery. 2025;181:109124.
   PubMed     Abstract available
   
   
   April 2025
10. OHSAWA M, Hamai Y, Okada M
    Reply to letter to the editor titled "Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone".
    Surgery. 2025 Apr 25:109386. doi: 10.1016/j.surg.2025.109386.
    PubMed    
    
    
    
11. WEBER T, Smaxwil C, Hermann M, Lenschow C, et al
    Results of (18)F-choline and (11)C-methionine positron emission tomography/computed tomography for the preoperative localization of hyperfunctional parathyroid glands in primary hyperparathyroidism.
    Surgery. 2025;180:109056.
    PubMed     Abstract available
    
    
    March 2025
12. YANG Y, Wang X, Kong Y
    Letter to the editor on "Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone".
    Surgery. 2025 Mar 17:109321. doi: 10.1016/j.surg.2025.109321.
    PubMed    
    
    
    February 2025
13. PAPINI P, Rossi L, Matrone A, De Renzis A, et al
    Prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma: 10-year impact on surgical and oncologic outcomes.
    Surgery. 2025;181:109258.
    PubMed     Abstract available
    
    
    
14. NGO S, Hu TX, Zhu CY, Hughes EG, et al
    Utility of prophylactic central dissection in papillary thyroid carcinoma with clinically apparent lymph node metastases isolated to the lateral neck.
    Surgery. 2025;181:109160.
    PubMed     Abstract available
    
    
    
15. AJAZ M
    Letter to the editor regarding "The role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study".
    Surgery. 2025 Feb 6:109164. doi: 10.1016/j.surg.2025.109164.
    PubMed    
    
    
    January 2025
16. MORENO LLORENTE P, Alberich Prats M, Garcia Barrasa A, Pascua Sole M, et al
    Postoperative and permanent hypocalcemia after indocyanine green (ICG) angiography-guided total thyroidectomy and central neck dissection: A retrospective cohort study.
    Surgery. 2025;181:109142.
    PubMed     Abstract available
    
    
    
17. LI K, Mao J, Yang X, Huang Y, et al
    Insights and comprehensive evaluation on "Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer".
    Surgery. 2025 Jan 22:109133. doi: 10.1016/j.surg.2024.109133.
    PubMed    
    
    
    December 2024
18. JI X, Liang W, Yu T, Ding C, et al
    Thyroid lobectomy for unilateral TNM T1 and T2 papillary thyroid carcinoma patients with lateral lymph node metastasis.
    Surgery. 2024;180:109028.
    PubMed     Abstract available
    
    
    
19. PENNESTRI F, Procopio PF, De Crea C, Raffaelli M, et al
    Response letter to the editor: "Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?".
    Surgery. 2024 Dec 19:109001. doi: 10.1016/j.surg.2024.109001.
    PubMed    
    
    
    
20. WANG R, Liu X, Cai H, Li B, et al
    A nomogram to predict long-term survival after resection for esophageal cancer: An observational study in northeast China.
    Surgery. 2024;178:108968.
    PubMed     Abstract available
    
    
    
21. VAGHAIWALLA TM, DeTrolio V, Saghira C, Akcin M, et al
    Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer.
    Surgery. 2024 Dec 16:108937. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
22. MACHENS A, Dralle H
    Letter to the editor: "Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?".
    Surgery. 2024 Dec 6:108960. doi: 10.1016/j.surg.2024.108960.
    PubMed    
    
    
    November 2024
23. CHEREAU N, Gaujoux S, Ghander C, Bertocchio JP, et al
    Parathyroid hormone-based algorithm reduces complications after total thyroidectomy.
    Surgery. 2024 Nov 28:108933. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    October 2024
24. PRATT CG, Long SA, Whitrock JN, Holm TM, et al
    "Thanks, but no thanks": Factors associated with patients who decline surgical intervention for thyroid cancer.
    Surgery. 2024 Oct 30:S0039-6060(24)00837-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
25. DICKERSON K, Milas M, Metzger R, Tomeh C, et al
    Neoadjuvant systemic therapy for inoperable differentiated thyroid cancers: Impact on tumor resectability.
    Surgery. 2024 Oct 28:S0039-6060(24)00706-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
26. RAMOS-FRESNEDO A, Phillips AL, Cantrell MC, Mobley EM, et al
    Cancer recurrence and survival among patients who underwent neoadjuvant treatment and surgery for esophageal cancer: A single-institution 10-year experience.
    Surgery. 2024 Oct 25:S0039-6060(24)00838-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
27. CRAIG S, Stretch C, Yeo C, Fan J, et al
    Prognostication with Thyroid GuidePx in the context of tall cell variants.
    Surgery. 2024 Oct 25:S0039-6060(24)00810-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
28. PROCOPIO PF, Pennestri F, Voloudakis N, La Rocca S, et al
    Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?
    Surgery. 2024 Oct 24:S0039-6060(24)00809-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
29. FUNG MHM, Luk Y, Lang BHH
    Early second radiofrequency ablation treatment gave rise to significantly greater nodule shrinkage at 12 months than single-session treatment for large-volume benign thyroid nodules.
    Surgery. 2024 Oct 24:S0039-6060(24)00807-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
30. NOVIS E, Glover A, Grady JP, Silvestri A, et al
    Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program.
    Surgery. 2024 Oct 17:S0039-6060(24)00781-5. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
31. OHSAWA M, Hamai Y, Emi M, Ibuki Y, et al
    Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone.
    Surgery. 2024 Oct 16:S0039-6060(24)00786-4. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
32. CARNABATU CJ, Fetzer DT, Tessnow A, Holt S, et al
    Avoidable biopsies? Validating artificial intelligence-based decision support software in indeterminate thyroid nodules.
    Surgery. 2024 Oct 12:S0039-6060(24)00697-4. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
33. TUMATI A, Marshall TE, Greenspun B, Chen Z, et al
    Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study.
    Surgery. 2024 Oct 10:S0039-6060(24)00704-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
34. ZHAO HH, Wilhelm SM
    Exploring ethnic diversity and clinical outcome variabilities in well-differentiated thyroid cancer among the Asian population.
    Surgery. 2024 Oct 8:S0039-6060(24)00698-6. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
35. KURTOM S, Liu JB, Doerfler WR, Calcaterra M, et al
    Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence.
    Surgery. 2024 Oct 8:S0039-6060(24)00710-4. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
36. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    Improvement in thyroid-specific quality of life following radiofrequency ablation of benign thyroid nodules: A USA study.
    Surgery. 2024 Oct 8:S0039-6060(24)00693-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
37. ARTHURS L, Fredericks S, Attlassy Y, Raghunathan R, et al
    Language-based exclusion associations with racial and ethnic disparities in thyroid cancer clinical trials.
    Surgery. 2024 Oct 7:S0039-6060(24)00696-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
38. JACOBS RC, Valukas CS, Visa MA, Logan CD, et al
    Association of operative time and approach on postoperative complications for esophagectomy.
    Surgery. 2024;176:1106-1114.
    PubMed     Abstract available
    
    
    September 2024
39. BRAAFLADT S, Allison H, Chung J, Mariash CN, et al
    Dose-dependent relationship between levothyroxine and health-related quality of life in survivors of differentiated thyroid cancer.
    Surgery. 2024 Sep 27:S0039-6060(24)00647-0. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
40. OH MY, Park D, Chai YJ, Kim K, et al
    Transoral robotic thyroidectomy: Lessons learned from consecutive series of 1,000 patients.
    Surgery. 2024 Sep 17:S0039-6060(24)00583-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
41. YANG Y, Jiang C, Su Y, Pan J, et al
    Occurrence and recovery of vocal cord paralysis after minimally invasive McKeown esophagectomy, risk factors, and clinical outcome.
    Surgery. 2024;176:713-720.
    PubMed     Abstract available
    
    
    August 2024
42. MACHENS A, Dralle H
    Response to letter to the editor on "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative, unifocal, nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Aug 30:S0039-6060(24)00222-8. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
43. KIM LT
    Invited commentary on: YMSY-D-23-01181_R2. Overexpression of human DNA polymerase theta (POLQ) is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Aug 20:S0039-6060(24)00543-9. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
44. JOGERST K, Zhang C, Chang YH, Gupta N, et al
    Dynamic volume-outcome association for esophagectomies: Do current volume thresholds still apply?
    Surgery. 2024;176:341-349.
    PubMed     Abstract available
    
    
    
45. MATHIESEN MR, Piper TB, Olsen AA, Damtoft A, et al
    Textbook outcome after esophagectomy: A retrospective study from a high-volume center.
    Surgery. 2024;176:350-356.
    PubMed     Abstract available
    
    
    July 2024
46. FEBRERO SANCHEZ B, Iborra E, Sanchez-Pedreno P, Ros-Madrid I, et al
    Analysis of the loss of phosphatase and tensin homolog expression in thyroid tissue for the diagnosis of Cowden syndrome.
    Surgery. 2024 Jul 6:S0039-6060(24)00384-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
47. PALLEIKO BA, Dickson KM, Crawford A, Shafique S, et al
    Preoperative risk factors for anastomotic leak after esophagectomy with gastric reconstruction: A 6-year national surgical quality improvement (NSQIP) database analysis.
    Surgery. 2024;176:93-99.
    PubMed     Abstract available
    
    
    
48. LEVENSON G, Coutrot M, Voron T, Gronnier C, et al
    Root cause analysis of mortality after esophagectomy for cancer: a multicenter cohort study from the FREGAT database.
    Surgery. 2024;176:82-92.
    PubMed     Abstract available
    
    
    June 2024
49. HOELZEN JP, Fortmann L, Roy D, Szardenings C, et al
    Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experience.
    Surgery. 2024 Jun 29:S0039-6060(24)00323-4. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
50. KNIPPER K, Jung JO, Straatman J, Brunner S, et al
    The role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study.
    Surgery. 2024 Jun 28:S0039-6060(24)00292-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
51. JIANG KY, Zhang SX, Hu WL, Deng ZQ, et al
    Prognostic factors for patients with pathologic T1-T2N+ esophageal squamous cell carcinoma: A retrospective study with external validation.
    Surgery. 2024 Jun 19:S0039-6060(24)00326-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
52. FRYE CC, Tennant L, Yeager A, Azimzadeh P, et al
    Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Jun 18:S0039-6060(24)00303-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    May 2024
53. XIAO X, Zhu Y, Li L, Liao Y, et al
    The effectiveness and safety of thermal ablation for thyroid carcinoma lymph node metastasis are affected by the diameter of metastatic lymph nodes: A meta-analysis.
    Surgery. 2024 May 21:S0039-6060(24)00233-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available
    
    
    
54. LUNARDI N, Jacob A, Elfenbein D, Schneider DF, et al
    Don't chase the adenoma: A probabilistic approach to imaging before parathyroidectomy.
    Surgery. 2024;175:1299-1304.
    PubMed     Abstract available
    
    
    
55. MA S, Zhu J, Xue M, Shen Y, et al
    Early postoperative endoscopy for predicting anastomotic leakage after minimally invasive esophagectomy: A large-volume retrospective study.
    Surgery. 2024;175:1305-1311.
    PubMed     Abstract available
    
    
    April 2024
56. PAPAVRAMIDIS T, Chorti A, Cheva A
    Response to "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Apr 3:S0039-6060(24)00131-4. doi: 10.1016/j.surg.2024.
    PubMed    
    
    
    
57. CHALLINE A, Kirouani M, Markar SR, Tzedakis S, et al
    MIRO study: Do the results of a randomized controlled trial apply in a real population?
    Surgery. 2024;175:1055-1062.
    PubMed     Abstract available
    
    
    March 2024
58. PIERCE K, Philips P, Egger ME, Scoggins CR, et al
    Developing sarcopenia during neoadjuvant therapy is associated with worse survival in esophageal adenocarcinoma patients.
    Surgery. 2024;175:718-725.
    PubMed     Abstract available
    
    
    February 2024
59. DYAS AR, Mungo B, Bronsert MR, Stuart CM, et al
    National trends in technique use for esophagectomy: Does primary surgeon specialty matter?
    Surgery. 2024;175:353-359.
    PubMed     Abstract available
    
    
    
60. DU J, Zeng T, Zhang S, Chen M, et al
    Comparison of indocyanine green-near-infrared fluorescence guided and traditional mediastinal lymphadenectomy during radical esophagectomy: A randomized controlled trial.
    Surgery. 2024;175:347-352.
    PubMed     Abstract available
    
    
    
61. FUJITA T, Sato K, Fujiwara N, Kajiyama D, et al
    A novel imaging technology to assess tissue oxygen saturation and its correlation with indocyanine green in the gastric conduit during thoracic esophagectomy.
    Surgery. 2024;175:360-367.
    PubMed     Abstract available
    
    
    January 2024
62. HEO DB, Won HR, Tae K, Kang YE, et al
    Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
    Surgery. 2024 Jan 27:S0039-6060(23)00967-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
63. LUND S, Schmitz JJ, Foster T, Dy B, et al
    Ethanol ablation of papillary thyroid carcinoma nodal metastases: Long-term outcomes.
    Surgery. 2024 Jan 8:S0039-6060(23)00908-X. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
64. LEE-SAXTON YJ, Palacardo F, Greenberg JA, Egan CE, et al
    Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Surgery. 2024;175:215-220.
    PubMed     Abstract available
    
    
    
65. WRIGHT K, Fisher JC, Rothberger GD, Prescott JD, et al
    Incidental (68)Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Surgery. 2024;175:228-233.
    PubMed     Abstract available
    
    
    December 2023
66. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
    Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
    Surgery. 2023 Dec 22:S0039-6060(23)00887-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
67. HU QL, Chen L, Kuo EJ, Lee JA, et al
    A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy.
    Surgery. 2023 Dec 13:S0039-6060(23)00871-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
68. OWUSU-BRACKETT N, Chakedis JM, Dedhia P, Gilliam C, et al
    Efficacy and safety of near-infrared fluorescence identification of the thoracic duct during left lateral neck dissection.
    Surgery. 2023 Dec 5:S0039-6060(23)00683-9. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    November 2023
69. SZABO YAMASHITA T, Shirali AS, Meas S, Sarli V, et al
    Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?
    Surgery. 2023 Nov 21:S0039-6060(23)00636-0. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
70. STURGEON C
    Addressing financial toxicity in thyroid cancer survivors in the United States.
    Surgery. 2023 Nov 10:S0039-6060(23)00755-9. doi: 10.1016/j.surg.2023.
    PubMed    
    
    
    
71. RUSSELL JO, Desai DD, Noel JE, Hussein M, et al
    Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experience.
    Surgery. 2023 Nov 10:S0039-6060(23)00725-0. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
72. SWANSON J, Roat-Shumway S, Cohn T, Luchette FA, et al
    Esophageal cancer: Does inaccuracy in clinical staging affect our ability to reach optimal outcomes?
    Surgery. 2023 Nov 4:S0039-6060(23)00518-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
73. RAGHUNATHAN R, Longstaff XR, Hughes EG, Li SJ, et al
    Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hurthle cell cytology.
    Surgery. 2023 Nov 3:S0039-6060(23)00634-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
74. LIN AC, Liu Z, Lee J, Ranvier GF, et al
    Generating a multimodal artificial intelligence model to differentiate benign and malignant follicular neoplasms of the thyroid: A proof-of-concept study.
    Surgery. 2023 Nov 2:S0039-6060(23)00635-9. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    October 2023
75. GIMBLET GR, Whitt J, Houson HA, Lin D, et al
    Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
    Surgery. 2023 Oct 31:S0039-6060(23)00631-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
76. TUMATI A, Egan CE, Lee-Saxton YJ, Marshall TE, et al
    Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.
    Surgery. 2023 Oct 29:S0039-6060(23)00626-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
77. CARLISLE KM, Brown JP, Kim J, Turner DJ, et al
    Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
    Surgery. 2023 Oct 21:S0039-6060(23)00638-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
78. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    The impact of social determinants of health on thyroid cancer mortality and time to treatment.
    Surgery. 2023 Oct 21:S0039-6060(23)00627-X. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
79. HUSSEIN M, Toraih E, Issa PP, Omar M, et al
    From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablation.
    Surgery. 2023 Oct 20:S0039-6060(23)00629-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
80. ZHAO HH, Wilhelm SM
    Pediatric thyroid cancer: Socioeconomic disparities and their impact on access to care.
    Surgery. 2023 Oct 18:S0039-6060(23)00600-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
81. DRALLE H, Brandenburg T, Weber F, Fuhrer-Sakel D, et al
    Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.
    Surgery. 2023 Oct 9:S0039-6060(23)00589-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    September 2023
82. VERM RA, Baker MM, Cohn T, Park S, et al
    Fragmented care, Commission on Cancer accreditation, and overall survival in patients receiving surgery and chemotherapy for esophageal cancer.
    Surgery. 2023 Sep 22:S0039-6060(23)00504-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
83. AKGUN E, Romero-Velez G, Berber E
    Assessing the efficacy of thyroid nodule radiofrequency ablation using patient-reported outcome measures.
    Surgery. 2023 Sep 21:S0039-6060(23)00514-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
84. SCHURING N, Donlon NE, Hagens ERC, Gootjes D, et al
    External validation of a nomogram predicting conditional survival after tri-modality treatment of esophageal cancer.
    Surgery. 2023 Sep 19:S0039-6060(23)00502-0. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
85. TERANISHI R, Makino T, Tanaka K, Yamashita K, et al
    Corrigendum to "Long-term survival and prognostic factors associated with curative conversion surgery for cT4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases": Surgery. 2023 Sep;174(3):558-566. doi:10.1016/j.surg.2023.05.040.
    Surgery. 2023 Sep 5:S0039-6060(23)00528-7. doi: 10.1016/j.surg.2023.
    PubMed    
    
    
    August 2023
86. MONTGOMERY KB, Fazendin JM, Broman KK
    Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States.
    Surgery. 2023 Aug 5:S0039-6060(23)00428-2. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
87. LAYDI M, Doussot A, Lakkis Z, Mathieu P, et al
    Anatomic patterns of anastomotic leaks after Ivor Lewis esophagectomy for cancer: Impact on management and outcomes.
    Surgery. 2023;174:247-251.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.